Regeneron EVP Marion McCourt reports sale of $984,194.76 in common shares
REGN•Regeneron EVP Commercial Marion McCourt sold 1,132 common shares on Oct. 30, 2026, at $869.43 per share, for $984,194.76. She held 10,871 shares directly and 219 through a 401(k) plan after the sale.
1. Share sale
Marion McCourt, executive vice president of commercial at Regeneron Pharmaceuticals, sold 1,132 common shares on Oct. 30, 2026, at $869.43 per share. The sale totaled $984,194.76.
2. Remaining holdings
Following the sale, McCourt held 10,871 common shares directly and another 219 through a 401(k) plan.
